Stocks and Investing Stocks and Investing
Tue, February 23, 2021
Mon, February 22, 2021
Sun, February 21, 2021
Fri, February 19, 2021
Thu, February 18, 2021

Doug Schenkel Maintained (TXG) at Buy with Increased Target to $200 on, Feb 18th, 2021


Published on 2024-10-27 15:40:42 - WOPRAI, Doug Schenkel
  Print publication without navigation


Doug Schenkel of Cowen & Co., Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $155 to $200 on, Feb 18th, 2021.

Doug has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Doug's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020


This is the rating of the analyst that currently disagrees with Doug


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $145 on, Wednesday, November 11th, 2020